2226507-05-5
2226507-05-5
Chemical Structure
BDP8900
- CAS. Nr.: 2226507-05-5
- Formula:C19H23N5S
- Molecular Weight:353.48
IUPAC Name: (S)-2-(4-(1,8-diazaspiro[5.5]undecan-8-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)thiazole
InChIKey: AZYKATVQZWSITP-IBGZPJMESA-N
SMILES: N1(C2=CC=NC3=C2C(C4=NC=CS4)=CN3)C[C@]5(CCCCN5)CCC1
Biological Activity: BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BDP8900 | BDP8900 is a potent and selective inhibitor of myotonic dystrophy-related Cdc42-binding kinases (MRCKα and MRCKβ). BDP8900 reduces substrate phosphorylation, leading to morphological changes, motility inhibition and invasiveness of cancer cells. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
